The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,477,660 in first-year total cost, median $836,260.
Most frequent study sections
- Special Emphasis Panel[ZAI1 SM-A (J1)]3
- ZAI1-SM-A(J1)1
Most frequent institutions
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- J. DAVID GLADSTONE INSTITUTES1
- JOHNS HOPKINS UNIVERSITY1
- UNIVERSITY OF MARYLAND BALTIMORE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Development of a Technology Platform for Engineering Single-Administration HIV Therapeutics1R56AI145018-01 | WEINBERGER, LEOR S | J. DAVID GLADSTONE INSTITUTES, CA | $975,928 | ZAI1 |
| 2019 | Sustained HIV Remission via Sequence-Specific Epigenetic Silencing of Latent Proviruses1R01AI144983-01 | ROMERIO, FABIO | UNIVERSITY OF MARYLAND BALTIMORE, MD | $841,926 | ZAI1 |
| 2019 | Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV1R01AI144997-01 | RAMRATNAM, BHARATWITWER, KENNETH W | JOHNS HOPKINS UNIVERSITY, MD | $830,593 | ZAI1 |
| 2019 | Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission1R01AI145024-01 | ALMO, STEVEN C.GOLDSTEIN, HARRIS | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $829,213 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.